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Abstract: 
Aim:  
Interstitial lung disease (ILD) in infants represents a rare and 
heterogenous group of disorders, distinct from those occurring in adults. In 
recent years a new entity within this category is being recognised, namely 
filamin A (FLNA) mutation related lung disease. Our aims are to describe 
the clinical and radiological course of patients with this disease entity to aid 
clinicians in the prognostic counseling and management of similar patients 
they may encounter.  
Method:  
A retrospective case note review was conducted of all patients treated at 
our institution (a specialist tertiary referral childrens’ centre) for genetically 
confirmed FLNA mutation related lung disease. The clinical presentation, 
evolution, management and radiological features were recorded and a 
medical literature review of Medline indexed articles was conducted.  
Results:  
We present a case series of four patients with interstitial lung disease and 
genetically confirmed abnormalities within the FLNA gene. Their imaging 
findings all reveal a pattern of predominantly upper lobe overinflation, 
coarse pulmonary lobular septal thickening and diffuse patchy atelectasis. 
The clinical outcomes of our patients have been variable ranging from 
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infant death, lobar resection and need for supplemental oxygen and 
bronchodilators.  
Conclusion:  
The progressive nature of the pulmonary aspect of this disorder and need 
for early aggressive supportive treatment make identification crucial to 
patient management and prognostic counseling.  
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Great Ormond Street 
London 
WC1N 3H 
Tel: 0207 405 9200 
 
Radiology Department 
Level 3 Southwood Building 
 
17th February 2017 
 
Dear Editor, Deputy Editor and Reviewers, 
 
Thank you for your re-review of our paper entitled ‘Filamin A (FLNA) Mutation – A Newcomer to 
the Childhood Interstitial Lung Disease (ChILD) Classification’ Manuscript ID: PPUL-16-0605. We 
have re-reviewed your additional comments and responded to these below.   
 
1) Reviewer 1: 
• Were other genetic causes of infant ChILD ruled out?  
Thank you for the reclarification – the patient in case 3 was also tested for cystic fibrosis and 
myotonin-protein kinase expansion, which were both negative. This has been added to the 
description of the case 3, in the fourth paragraph, fourth and fifth lines. 
 
• Was the FLNA variant predicted to be damaging based on analyses using variant effect 
prediction tools? 
The FLNA variant for case 3 was described by the genetic laboratory as being novel, without 
any prior report or awareness of pathogenicity in other patients. As such, the genetic report 
stated that pathogenicity of this variant was ‘uncertain’ and could not give us a prediction of 
pathogenic likelihood.  
 
We have however included this novel mutation in our case series as we felt it was important 
to highlight the uncertainty that can come with FLNA testing and also to raise awareness of 
this variant, the symptoms and radiographical abnormalities in our patient, should this be 
encountered by others in the future.        
 
• Abstract, Results: I would caution using ‘interstitial lung pathologies’ as some might take this 
to mean histopathology showing interstitial changes, as biopsy was only done for 2/4 patients. 
The word ‘pathologies’ has been amended to ‘disease’ to remove any reader assumption 
regarding tissue confirmed histology.  
 
• Page 22, line 53: ‘patient’s parents’ should read ‘patients’ parents’. 
• Page 23, line 50: Eliminate double periods. 
• Page 25, line 17: ‘Child’ should read ‘ChILD’ 
• Table 1: ‘chocking’ should read ‘choking’ 
Thank you – all typos listed above have been corrected. 
 
Once again I thank the reviewers for their invaluable input, support and interest of our manuscript.  
We do sincerely hope that you will now find it publishable in the updated state. 
 
Best wishes, 
Susan Shelmerdine (on behalf of all co-authors). 
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Abbreviations List: 
ASD – atrial septal defect 
BiPAP - bilevel positive airway pressure 
ChILD – Children’s Interstitial Lung Disease 
CPAP – continuous positive airway pressure 
CT – computed tomography 
ECHO – echocardiography 
ETT – endotracheal tube 
FLNA - Filamin A  
HFOV – high flow oxygen ventilation 
ILD – interstitial lung diseases 
PDA – patent ductus arteriosus 
PFO – patent foramen ovale 
PICU – paediatric intensive care unit 
MDT – multidisciplinary team 
NIV – non-invasive mechanical ventilation 
VSD – ventricular septal defect 
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Abstract: 
Aim: 
Interstitial lung disease (ILD) in infants represents a rare and heterogenous 
group of disorders, distinct from those occurring in adults. In recent years a 
new entity within this category is being recognised, namely filamin A (FLNA) 
mutation related lung disease. Our aims are to describe the clinical and 
radiological course of patients with this disease entity to aid clinicians in the 
prognostic counseling and management of similar patients they may 
encounter. 
Method: 
A retrospective case note review was conducted of all patients treated at our 
institution (a specialist tertiary referral childrens’ centre) for genetically 
confirmed FLNA mutation related lung disease. The clinical presentation, 
evolution, management and radiological features were recorded and a 
medical literature review of Medline indexed articles was conducted. 
Results:  
We present a case series of four patients with interstitial lung disease and 
genetically confirmed abnormalities within the FLNA gene. Their imaging 
findings all reveal a pattern of predominantly upper lobe overinflation, coarse 
pulmonary lobular septal thickening and diffuse patchy atelectasis. The 
clinical outcomes of our patients have been variable ranging from infant 
death, lobar resection and need for supplemental oxygen and bronchodilators. 
Conclusion:  
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The progressive nature of the pulmonary aspect of this disorder and need for 
early aggressive supportive treatment make identification crucial to patient 
management and prognostic counseling.  
 
Introduction: 
Interstitial lung disease (ILD) in infants represents a rare and heterogenous 
group of disorders, distinct from those occurring in adults. In 2007 the ChILD 
(Children’s Interstitial Lung Disease) research co-operative proposed a new 
classification scheme for diffuse pulmonary lung diseases encompassing a 
variety of genetic and developmental aetiologies1. The classification was 
based upon biopsy and imaging results from eleven centres contributing 187 
cases of diffuse lung disease in infancy over a 5 year study period. This has 
been incorporated into the latest 2013 American Thoracic Society Clinical 
Practice Guideline: Classification, Evaluation and Management of Childhood 
Interstitial Lung disease in Infancy and serves as a framework by which to 
build upon, with discovery and delineation of molecular and specific 
aetiologies adding to this classification with time.23. In recent years a new 
disease entity is being increasingly recognised, namely filamin A (FLNA) 
mutation related lung disease. 
  
Filamin A is an actin-binding protein expressed ubiquitously within the body 
with multiple roles both in cell signaling and maintenance of cell shape and 
motility4,5. A well-known association already exists between this mutation and 
disorders of neuronal migration, vascular function, connective tissue integrity 
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and skeletal development6 however pulmonary manifestations are only just 
being described with four published case reports to date7,8,9, 10 and a further 
five patients altogether reported within two separate poster abstract 
publications11,12.  
 
In the cases reported, radiographic features have mimicked those of 
congenital lobar emphysema with hyperlucent pulmonary parenchyma, multi-
lobar hyperinflation and pulmonary vascular attenuation. Pathology obtained 
from lung biopsy or resection have revealed a combination of alveolar 
simplification, emphysematous changes and pulmonary arteriopathy 
suggesting that mutations of FLNA appear to result in alveolar growth 
abnormality and thus reflect another causal aetiology within the  referenced 
classifications1,13. In nearly all cases treatment has involved either lobar 
resection or lung transplantation7,8,11 with only one case reported where 
supportive therapy was successful9. 
 
Given the progressive nature of this disease and potentially fatal outcomes, 
we present our own case series of four patients with genetically confirmed 
FLNA mutation and associated pulmonary manifestations. This case series 
will focus on clinical and radiographical findings of this condition with the aim 
of raising awareness and improving identification of this rare entity.  
 
Methods: 
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A retrospective case note review was conducted of all patients treated at our 
institution (a specialist tertiary referral childrens’ centre) for genetically 
confirmed FLNA mutation related lung disease. Patients tested for FLNA 
mutation without lung disease were excluded from this analysis. 
 
At our institution, all genetic testing for FLNA is performed on peripheral blood 
samples, at an off-site UKAS accredited genetic laboratory by use of bi-
directional Sanger sequencing. Determination of pathogenicity of variants are 
carried out at the laboratory using bioinformatics software Alamut v 2.0 
(Interactive Biosoftware, Rouen, France).   
 
The clinical presentation, evolution, management and radiological features 
were recorded and a medical literature review of Medline indexed articles of 
previously described cases was conducted. The parents of all patients 
described in this article have provided consent for discussion of their 
children’s cases.  
  
Results: 
Over the last 10 years at our institution, there have been 4 genetically 
confirmed cases of FLNA mutation related lung disease. An overview of the 
genetic abnormalities, key radiographical features and clinical outcomes are 
provided in Table 1. A detailed case review of each patient is outlined below. 
 
Case 1 
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A female infant with a normal antenatal course was delivered via elective 
Caesarean section at 36 + 5 weeks gestation due to breech presentation. The 
delivery was otherwise unremarkable and the patient was discharged home 
on her second day of life.  Although initially thriving, her weight gain plateaued 
at 6-8 weeks of age.  
 
At three months of age the patient was admitted to her local hospital with 
sudden onset difficulty in breathing. Oxygen saturations were low at 80% in 
air, improving to 100% with 2 litres of oxygen via nasal cannula. A chest 
radiograph (Figure 1) was performed which demonstrated right upper zone 
consolidation, mediastinal shift to the right and hyperinflation of the left lung 
with septal thickening. An empirical course of Ceftriaxone was started, 
however respiratory symptoms deteriorated overnight requiring intubation and 
high frequency oscillatory ventilation (HFOV).  
 
The patient was transferred to our institution for further medical input. On 
arrival the patient showed signs of septic shock requiring aggressive fluid 
resuscitation and inotropic support. Transthoracic echocardiogram revealed 
pulmonary hypertension, small patent ductus arteriosus (PDA) and patent 
foramen ovale (PFO). A right pleural effusion was drained on admission and 
did not culture any micro-organisms. A bronchioalveolar lavage was initially 
positive for pneumocystis carinii and a three week course of co-trimoxazole 
was started. Repeat lavage one week later was negative.  
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A computed tomography (CT) of the chest  (Figure 2 a to c) revealed a right 
sided pneumothorax, extensive bilateral chronic lung changes with left sided 
abnormal architectural changes and regions of centrilobar emphysema.  A 
tube oesophagram did not reveal a tracheo-oesophagela fistula.  
 
The patient continued to have a difficult clinical course, with failure to 
extubate, increasing oxygen requirements and recurrent admissions to 
paediatric intensive care unit. Repeat thoracic CT studies did not reveal any 
significant change in appearances apart from resolution of a previous right 
pneumothorax (Figure 2 d to f).  
 
Given the lack of clear diagnosis for the lung changes, molecular genetic 
testing was sought. There was no evidence for cystic fibrosis, pulmonary 
surfactant protein B (SFTPB) or C (SFTPC) ABCA3 gene deficiencies or any 
immunodeficiencies.  
 
At the age of 5 months, she underwent PDA ligation and right lung wedge 
biopsy (Figure 3 a). The biopsy results demonstrated poor alveolar 
development and immaturity with mild thickening of the small arteries. A post-
operative echocardiogram revealed reduction in pulmonary pressures with 
only a small residual atrial septal defect (ASD) remaining. 
 
The patient was eventually weaned from ventilation and extubated at age 6 
months onto bilevel positive airway pressure (BiPAP) support. She was then 
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cycled to continuous positive airway pressure (CPAP) for increasing durations 
and discharged from the intensive care unit to the ward. Shortly after she 
developed pyrexia and loose stools rapidly escalating to respiratory distress 
and arrest. She was re-intubated and ventilated and transferred to the 
paediatric intensive care unit (PICU). After discussion with family and medical 
teams, the decision was made to form a tracheostomy at age 8 months.  
 
Unfortunately the patient was unable to recover from the event, requiring 
continued oxygen and ventilator support, and died shortly after aged 9 
months. A postmortem examination was interpreted as atypical congenital 
alveolar dysplasia. There were no areas of normal lung tissue, nor any large 
cysts or active infection (Figure 3 b). Further genetic testing performed post-
mortem revealed a mutation in the FLNA gene, felt to be contributory to the 
severe lung changes. 
 
 
Case 2  
A term female infant with an unremarkable antenatal course was noted to 
have poor weight gain during the early months of her life. At the age of 7 
months, her parents reported one episode of choking during a swimming 
outing in a chlorinated pool. There was no concern regarding near drowning 
or requirement for poolside resuscitation however the parents decided to take 
the  infant  to her local hospital for review. An admission chest radiograph was 
performed and demonstratedemphysematous changes within the right lung, 
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which would not have been consistent with the clinical history. A chest CT 
was performed during the same admission which confirmed the radiograph 
findings of hyperinflation of the right upper and middle lobes with areas of 
bronchial wall thickening and dilatation in the lower lobes (Figure 4). 
 
The patient continued to have multiple episodes of intercurrent pulmonary 
infections necessitating prolonged hospital admission and escalation in 
ventilatory support with 100% oxygen via high flow nasal cannulae with a 
maximal FiO2 of 45%.  
 
During her hospital admission, she was discovered to have a PDA which was 
ligated. Transpulmonary gradient pressures measured at this time were 
elevated and a course of sildenafil initiated. A transthoracic echocardiogram 
revealed a hypertrophied right ventricle with preserved function and no 
significant chamber dilatation.  
 
Given the destructive lung changes, genetic analysis was sought and a 
mutation of the FLNA gene was identified. Due to the known association 
between FLNA mutation and neurological abnormalities, an MRI of the brain 
was performed demonstrating periventricular nodular heterotopia (PVNH), 
although the patient was not suffering from any neurological symptoms at this 
stage. 
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During the course of the following months the chest radiograph changes were 
progressively deteriorating (Figure 5) with increasing right upper lobe 
hyperinflation, left sided mediastinal shift and reduced aeration within the left 
lung. After careful consideration and discussion at the respiratory multi-
disciplinary team (MDT) meeting, a right upper lobectomy was performed  at 
18 months of age. The histopathology results of the resected lobe 
demonstrated emphysematous changes but without significant inflammatory 
lung disease (Figure 6).   
 
The patient made a slow, but successful recovery post-lobectomy with 
improvements in chest symptoms, saturating up to 98% on room air. She has 
had minor viral illnesses requiring additional supplemental oxygen but no 
further respiratory support. She is currently 4 years old and progressing well 
clinically. Her pulmonary vasodilators are slowly being weaned and she no 
longer requires diuretic medications. The latest echocardiogram does 
continue to demonstrate some signs of elevated pulmonary arterial pressure 
and therefore she continues to be monitored in our institution’s outpatient 
clinic for signs of aortic root dilatation or valvulopathy.  
 
Case 3  
This female infant was born via vaginal delivery through meconium stained 
liquor at 40 +4 weeks gestation. At birth she was transferred and intubated on 
the neonatal intensive care unit (NICU) due to increased work of breathing 
and low oxygen saturations. The patient continued to have a difficult neonatal 
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course requiring high flow oxygen ventilation, nitric oxide and inotropic 
support.  
 
After multiple unsuccessful attempts at extubation, the patient was transferred 
to a tertiary specialist children’s hospital for further care. A chest CT at this 
stage, aged 2 months, revealed pan lobular emphysematous changes within 
both lungs with hyperinflation of the upper lobes and right middle lobe (Figure 
7).  At three months of age she was successfully extubated and placed on 
non-invasive mechanical ventilation (NIV) support. A bronchoscopy at this 
time demonstrated left lower lobe bronchomalacia and multiple bronchial 
stenoses. A transthoracic echocardiography revealed a structurally normal 
heart without any evidence of pulmonary hypertension. 
 
After a prolonged course of NIV support and difficulty weaning from CPAP, 
the decision was made to site a tracheostomy at 6 months of age. The patient 
was slowly established on a portable ventilator via the tracheostomy with 
improvement in her baseline respiratory rate and work of breathing. She was 
then transferred to our institution for long term ventilation management. The 
admission chest radiograph (Figure 8) shows bilateral bronchial wall 
thickening with persistent hyperlucency and inflation of the upper lobes. 
 
During her inpatient stay, she was difficult to wean from ventilation, 
developing recurrent episodes of wheezing and bronchoconstriction which 
were responsive to Ipratropium bromide and Salbutamol. Genetic testing was 
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sought based on re-review of the external CT imaging. This was negative for 
cystic fibrosis and myotonin-protein kinase expansion but  confirmed a novel 
variant missense mutation within the filamin A gene. Given the uncertainty 
regarding pathogenicity, the patient’s immediate family members were all 
reviewed and tested for FLNA gene mutation. The patient’s mother and 
younger sister were asymptomatic but found to have the identical missense 
mutation, and the patient’s father did not. After prolonged discussion and 
genetic consultation, given the absence of other explainable lung disease, the 
consensus hypothesis was that the lung disease may have been manifested 
by an invoked unfavourable X inactivation in the patient.  
 
Over the next years, the patient slowly improved with bronchodilator 
nebulization and satisfactory gas exchange on lower CPAP, tolerating periods 
on the Swedish nose during the day. She is now 3 years old and has had her 
tracheostomy removed within the last 6 months. She is continuing to gain 
weight and only requires the usage of bronchodilator inhalers for a recurrent 
wheeze. 
 
Case 4  
This female infant was born at 38 weeks gestation with a normal antenatal 
and immediate neonatal course. She was admitted to her local hospital with 
suspected viral bronchiolitis at 3 months of age and required supplemental 
oxygen. An echocardiogram at this time revealed a secundum ASD with 
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bidirectional flow, mildly dilated and hypertrophied right ventricle and right 
atrium as well as pulmonary hypertension. 
 
The chest radiograph appearances at this stage included right upper lobe 
hyperinflation with right middle lobe and left lower lobe atelectasis (Figure 9). 
The subsequent chest CT demonstrated dilatation of the central pulmonary 
artery with bilateral extensive chronic lung disease with nodular change and 
bronchial wall thickening. In addition, hyperinflation of the upper lobes 
bilaterally were seen (Figure 10). 
 
The patient was admitted to our institution for a hybrid procedure involving 
both cardiac catheterisation and cardiac MRI. These studies revealed a PDA, 
confirmed bidirectional flow through the ASD and significant pulmonary 
arterial hypertension. The systemic and pulmonary venous connections were 
normal.  
 
A respiratory consultation was sought and the pulmonary hypertension was 
presumed to be secondary to the diffuse lung disease. The patient was 
started on Bosentan in addition to her regular dose of Sildenafil. Investigations 
for aspiration, gastro-oesophageal reflux, immunodeficiency and cystic 
fibrosis were all negative.  
 
In view of the severe early onset cystic lung disease, she was screened for a 
Filamin A gene mutation, which was confirmed. She is currently 6 years old, 
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and continues on supplementary oxygen support of 1L at home and 
pulmonary vasodilators. 
 
Discussion: 
Our case series has demonstrated a variable outcome and management 
course for four patients seen with confirmed FLNA gene mutations occurring 
with interstitial lung disease. One patient required surgical intervention in the 
form of a right upper lobectomy after which a dramatic clinical improvement 
was observed, two patients were treated with supplementary oxygen and 
ventilatory support with pulmonary arterial vasodilators and have 
demonstrated a steady but slow improvement in respiratory symptoms and 
one patient died in infancy having been treated with maximal medical 
therapies and multiple episodes of mechanical ventilatory support.  
 
Compared to the limited number of previously published cases (summarised 
in Table 2), our case series show similar features with our patients having an 
early age of onset of respiratory symptoms, presence of cardiac co-
morbidities, pulmonary arterial hypertension (seen on echocardiography) and 
in one patient, the confirmatory diagnosis of periventricular nodular 
heterotopia on brain MRI. On chest imaging, all our patients demonstrated 
features both on radiography and CT of predominantly upper lobe 
hyperinflation and segmental basal atelectasis. This echoes previous cases 
where imaging appearances have been described as those featuring a 
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combination of  bronchopulmonary dysplasia, bronchomalacia and congenital 
lobar emphysema12.  
 
With regards to the cardiac co-morbidities, two of our patients were found to 
have a patent ductus arteriosis, which was also seen in 5 previously reported 
FLNA associated lung disease cases
7,11
 and was the second commonest 
associated cardiac abnormality within 17.6% (6 patients) of patients with 
FLNA associated PVNH (second only to aortic valvular insufficiency)Error! 
Bookmark not defined.. This illustrates the importance of echocardiographic findings 
in this cohort of patients and the need for future extended medical 
surveillance from a cardiovascular standpoint. 
 
Although one of our four cases was found to have PVNH on brain imaging, 
none of our cases reported neurological symptoms. This may be explained by 
the young age group or case mix of our cohort. Lange et al14 report in their 
large case series, of 34 patient with detailed clinical history and FLNA 
associated PVNH, many patients (n=10) had either none or minor 
neurological symptoms (e.g. headaches) whilst the remainder had seizure 
onset during adolescence or adulthood (n = 20). Interestingly, only 2 patients 
in this cohort had any respiratory symptoms described (these are not detailed 
further, apart from being described as ‘obstructive lung disease’). Whilst we 
acknowledge a strong association between FLNA mutation and PVNH exists, 
given the young age of our patients, lack of neurological symptoms and 
increased risk from general anaesthesia in order to perform the MRI studies 
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(due to their lung disease), this was not felt to be clinically indicated at the 
present stage. The patients’ parents have all been extensively counseled on 
associated anomalies in FLNA mutations, and should neurological symptoms 
arise, further neurological examinations would be arranged. 
 
In terms of treatment, in contrast to 4 other prior cases in the literature11, none 
of the patients in our series required lung transplantation. Whilst one of our 
patients died at an early age and may not have been a suitable surgical 
candidate, transplantation may be an alternative treatment in severe cases 
where supportive therapies do not appear to work. Additionally, the individual 
FLNA mutations identified within our subgroup are all novel and provide a 
record by which future cases with FLNA mutations can be compared to help 
guide management and provide information on potential patient prognosis. In 
one of our cases (case 3), the genetic mutation was a missense variant 
mutation, highlighting a clinical diagnostic dilemma and necessitating genetic 
testing of several family members. In the absence of other explainable causes 
for the patient’s lung disease, this was assumed to be contributory and has 
been included in this case series in the hope that our findings may aid in 
patient counseling and for comparison to future similar cases to emerge in the 
medical literature. 
 
Genetic analysis and counseling can also aid family members, particularly in 
the setting of family planning, to determine options for prenatal genetic testing 
or preimplantation genetic diagnosis for further pregnancies. However there 
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are limitations to this, one being the discovery of missense variant mutations 
as highlighted and described in case 3 which may pose a diagnostic dilemma. 
In addition, although our case series highlights the clinical and radiological 
findings of lung disease in patients with confirmed FLNA mutations, the 
spectrum of such lung disease is still to be established and there may be 
‘missed cases’ of FLNA mutation in patients with potentially milder forms of 
the disease, being treated and labeled as having ‘abnormalities of lung 
growth’. This may be an interesting area for further research work. 
 
The pathogenesis of lung disease associated with FLNA mutations is unclear 
but a variety of hypotheses have been proposed. One explanation may be 
due to abnormal binding properties between Filamin A and beta integrin cell 
adhesion receptors, crucial in airway development15. The association between 
FLNA mutation with connective tissue disorders16 may also suggest interplay 
with other gene abnormalities within the same functional pathway. These 
explanations have also been proposed to account for the associated cardiac 
anomalies in many observed cases of FLNA associated lung disease.  
 
An alternative mechanism may be from atypical interactions of Filamin A with 
the cystic fibrosis transmembrane regulator (CFTR) thereby destabilizing 
chloride channel function in the airways17. This is however felt to be a less 
likely cause for the pulmonary features as florid bronchiectasis and impaired 
mucociliary fluid clearance has only been described in one patient so far with 
FLNA mutation12. Furthermore poor immunological function with a super-
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added infective aetiology has been suggested due to the role played by 
Filamin A in T cell activation and interleukin production18, however patients 
with the FLNA mutation have not shown susceptibility to any specific 
organisms despite many of the patients in our case series regularly presenting 
to hospital in childhood with recurrent pulmonary infections. 
 
Conclusion 
We present the clinical radiological, cardiac and histological features of FLNA 
gene mutation ChILd. This diagnosis should be considered for atypical diffuse 
lung disease with the hallmark feature of marked hyperinflation19, 
predominantly in the upper lobe distribution with accompanying pulmonary 
arterial hypertension in the majority of cases. There may be a potential 
association with periventricular nodular heterotopia (PNH)16. Whilst the 
treatment options may be predominantly supportive, our case series has 
shown that some clinical improvements may be achieved and that the 
prognosis is variable.  
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Image Legends 
Figure 1   
Chest radiograph of case 1 at age 3 months demonstrating hyperinflation and 
lucency within the left lung with mediastinal shift to the right. Fine interstitial 
thickening and septations are noted in the left lower zone. There is right upper lobe 
consolidation.  
 
Figure 2 (a-f) 
Case 1: Serial axial chest CT images (with lung windows) are displayed 
demonstrating lung changes with age. The top row (a to c) highlights imaging 
appearances within the upper, middle and lower zones respectively at 3 months of 
age. There is a moderate sized right pneumothorax with underlying ground glass 
change in the lung parenchyma. The left lung is hyperinflated with interlobular septal 
thickening and areas of air trapping. The bottom row (d to f) demonstrates lung 
appearances at 5 months of age reflecting on-going left lung hyperinflation and 
septal thickening. The pneumothorax is no longer present. 
 
Figure 3 
Haematoxylin and eosin stained histopathology images of (a) the initial wedge 
biopsy of lung including the pleura and (b) a representative post-mortem section of 
the patient’s lung from case 1. The wedge biopsy reveals simplification of the 
alveolar architecture with dilatation of the distal airspaces. There is peribronchial 
fibrosis and focal haemorrhage. The post-mortem section demonstrates thickened 
alveolar septa and contain double capillary loops. This appearance was present 
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throughout the lung and is the diagnostic feature of atypical congenital alveolar 
dysplasia. There is marked intra-alveolar oedema. Elsewhere within the lung there 
was fibrosis and airspace dilatation.  
 
Figure 4 
Case 2: Axial chest computed tomography images of the upper (a), middle (b) and 
lower (c) zones at four months of age. Right upper and middle lobe hyperinflation 
with patchy ground glass opacification and atelectasis are present within the left lung 
and right lower lobe.  
 
Figure 5 
Serial chest radiographs from case 2 performed at (a) 8 months of age and (b) 15 
months of age reveal progressive right sided hyperinflation, mediastinal shift to the 
left and diffuse ground glass opacification within the left lung. 
 
Figure 6 
Histopathology lung biopsy image from case 2 with elastic van Gieson staining. 
There is marked dilatation of the distal air spaces without thickening of the walls. The 
included muscular pulmonary arteries are thick walled in keeping with pulmonary 
arterial hypertension. There is also some artefactual alveolar haemorrhage. 
 
Figure 7 
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Case 3: Axial chest CT images of the (a) upper and (b) lower lobes at 2 months of 
age demonstrate upper lobe hyperinflation with sparse pulmonary vascular markings 
and bibasal medial atelectatic changes.  
 
Figure 8 
A supine chest radiograph of case 3 performed at 10 months of age demonstrates 
persistent upper lobe hyperinflation, flattening of both hemidiaphragms and perihilar 
airspace changes. The patient has a tracheostomy in situ at this stage and is fed via 
a nasogastric tube. 
 
Figure 9 
Chest radiograph of patient in case 4 performed at 8 months of age demonstrates 
right upper lobe hyperinflation and atelectasis within the right midzone and left lower 
lobe. 
 
Figure 10 
Axial chest computed tomography images of case 4 of the (a) upper lobes and (b 
and c) lung bases reveal marked overinflation of both upper lobes and the right 
middle lobe with bilateral lower lobe atelectasis 
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Abstract: 
Aim: 
Interstitial lung disease (ILD) in infants represents a rare and heterogenous 
group of disorders, distinct from those occurring in adults. In recent years a 
new entity within this category is being recognised, namely filamin A (FLNA) 
mutation related lung disease. Our aims are to describe the clinical and 
radiological course of patients with this disease entity to aid clinicians in the 
prognostic counseling and management of similar patients they may 
encounter. 
Method: 
A retrospective case note review was conducted of all patients treated at our 
institution (a specialist tertiary referral childrens’ centre) for genetically 
confirmed FLNA mutation related lung disease. The clinical presentation, 
evolution, management and radiological features were recorded and a 
medical literature review of Medline indexed articles was conducted. 
Results:  
We present a case series of four patients with interstitial lung pathologies 
disease and genetically confirmed abnormalities within the FLNA gene. Their 
imaging findings all reveal a pattern of predominantly upper lobe overinflation, 
coarse pulmonary lobular septal thickening and diffuse patchy atelectasis. 
The clinical outcomes of our patients have been variable ranging from infant 
death, lobar resection and need for supplemental oxygen and bronchodilators. 
Conclusion:  
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The progressive nature of the pulmonary aspect of this disorder and need for 
early aggressive supportive treatment make identification crucial to patient 
management and prognostic counseling.  
 
Introduction: 
Interstitial lung disease (ILD) in infants represents a rare and heterogenous 
group of disorders, distinct from those occurring in adults. In 2007 the ChILD 
(Children’s Interstitial Lung Disease) research co-operative proposed a new 
classification scheme for diffuse pulmonary lung diseases encompassing a 
variety of genetic and developmental aetiologies1. The classification was 
based upon biopsy and imaging results from eleven centres contributing 187 
cases of diffuse lung disease in infancy over a 5 year study period. This has 
been incorporated into the latest 2013 American Thoracic Society Clinical 
Practice Guideline: Classification, Evaluation and Management of Childhood 
Interstitial Lung disease in Infancy and serves as a framework by which to 
build upon, with discovery and delineation of molecular and specific 
aetiologies adding to this classification with time.23. In recent years a new 
disease entity is being increasingly recognised, namely filamin A (FLNA) 
mutation related lung disease. 
  
Filamin A is an actin-binding protein expressed ubiquitously within the body 
with multiple roles both in cell signaling and maintenance of cell shape and 
motility4,5. A well-known association already exists between this mutation and 
disorders of neuronal migration, vascular function, connective tissue integrity 
Page 34 of 75
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
FLNA mutation – a newcomer to the ChILD classification 
Page 6 
 
 
and skeletal development6 however pulmonary manifestations are only just 
being described with four published case reports to date7,8,9, 10 and a further 
five patients altogether reported within two separate poster abstract 
publications11,12.  
 
In the cases reported, radiographic features have mimicked those of 
congenital lobar emphysema with hyperlucent pulmonary parenchyma, multi-
lobar hyperinflation and pulmonary vascular attenuation. Pathology obtained 
from lung biopsy or resection have revealed a combination of alveolar 
simplification, emphysematous changes and pulmonary arteriopathy 
suggesting that mutations of FLNA appear to result in alveolar growth 
abnormality and thus reflect another causal aetiology within the  referenced 
classifications1,13. In nearly all cases treatment has involved either lobar 
resection or lung transplantation76,87,1110 with only one case reported where 
supportive therapy was successful98. 
 
Given the progressive nature of this disease and potentially fatal outcomes, 
we present our own case series of four patients with genetically confirmed 
FLNA mutation and associated pulmonary manifestations. This case series 
will focus on clinical and radiographical findings of this condition with the aim 
of raising awareness and improving identification of this rare entity.  
 
Methods: 
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A retrospective case note review was conducted of all patients treated at our 
institution (a specialist tertiary referral childrens’ centre) for genetically 
confirmed FLNA mutation related lung disease. Patients tested for FLNA 
mutation without lung disease were excluded from this analysis. 
 
At our institution, all genetic testing for FLNA is performed on peripheral blood 
samples, at an off-site UKAS accredited genetic laboratory by use of bi-
directional Sanger sequencing. Determination of pathogenicity of variants are 
carried out at the laboratory using bioinformatics software Alamut v 2.0 
(Interactive Biosoftware, Rouen, France).   
 
The clinical presentation, evolution, management and radiological features 
were recorded and a medical literature review of Medline indexed articles of 
previously described cases was conducted. The parents of all patients 
described in this article have provided consent for discussion of their 
children’s cases.  
  
Results: 
Over the last 10 years at our institution, there have been 4 genetically 
confirmed cases of FLNA mutation related lung disease. An overview of the 
genetic abnormalities, key radiographical features and clinical outcomes are 
provided in Table 1. A detailed case review of each patient is outlined below. 
 
Case 1 
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A female infant with a normal antenatal course was delivered via elective 
Caesarean section at 36 + 5 weeks gestation due to breech presentation. The 
delivery was otherwise unremarkable and the patient was discharged home 
on her second day of life.  Although initially thriving, her weight gain plateaued 
at 6-8 weeks of age.  
 
At three months of age the patient was admitted to her local hospital with 
sudden onset difficulty in breathing. Oxygen saturations were low at 80% in 
air, improving to 100% with 2 litres of oxygen via nasal cannula. A chest 
radiograph (Figure 1) was performed which demonstrated right upper zone 
consolidation, mediastinal shift to the right and hyperinflation of the left lung 
with septal thickening. An empirical course of Ceftriaxone was started, 
however respiratory symptoms deteriorated overnight requiring intubation and 
high frequency oscillatory ventilation (HFOV).  
 
The patient was transferred to our institution for further medical input. On 
arrival the patient showed signs of septic shock requiring aggressive fluid 
resuscitation and inotropic support. Transthoracic echocardiogram revealed 
pulmonary hypertension, small patent ductus arteriosus (PDA) and patent 
foramen ovale (PFO). A right pleural effusion was drained on admission and 
did not culture any micro-organisms. A bronchioalveolar lavage was initially 
positive for pneumocystis carinii and a three week course of co-trimoxazole 
was started. Repeat lavage one week later was negative.  
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A computed tomography (CT) of the chest  (Figure 2 a to c) revealed a right 
sided pneumothorax, extensive bilateral chronic lung changes with left sided 
abnormal architectural changes and regions of centrilobar emphysema.  A 
tube oesophagram did not reveal a tracheo-oesophagela fistula.  
 
The patient continued to have a difficult clinical course, with failure to 
extubate, increasing oxygen requirements and recurrent admissions to 
paediatric intensive care unit. Repeat thoracic CT studies did not reveal any 
significant change in appearances apart from resolution of a previous right 
pneumothorax (Figure 2 d to f).  
 
Given the lack of clear diagnosis for the lung changes, molecular genetic 
testing was sought. There was no evidence for cystic fibrosis, pulmonary 
surfactant protein B (SFTPB) or C (SFTPC) ABCA3 gene deficiencies or any 
immunodeficiencies.  
 
At the age of 5 months, she underwent PDA ligation and right lung wedge 
biopsy (Figure 3 a). The biopsy results demonstrated poor alveolar 
development and immaturity with mild thickening of the small arteries. A post-
operative echocardiogram revealed reduction in pulmonary pressures with 
only a small residual atrial septal defect (ASD) remaining. 
 
The patient was eventually weaned from ventilation and extubated at age 6 
months onto bilevel positive airway pressure (BiPAP) support. She was then 
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cycled to continuous positive airway pressure (CPAP) for increasing durations 
and discharged from the intensive care unit to the ward. Shortly after she 
developed pyrexia and loose stools rapidly escalating to respiratory distress 
and arrest. She was re-intubated and ventilated and transferred to the 
paediatric intensive care unit (PICU). After discussion with family and medical 
teams, the decision was made to form a tracheostomy at age 8 months.  
 
Unfortunately the patient was unable to recover from the event, requiring 
continued oxygen and ventilator support, and died shortly after aged 9 
months. A postmortem examination was interpreted as atypical congenital 
alveolar dysplasia. There were no areas of normal lung tissue, nor any large 
cysts or active infection (Figure 3 b). Further genetic testing performed post-
mortem revealed a mutation in the FLNA gene, felt to be contributory to the 
severe lung changes. 
 
 
Case 2  
A term female infant with an unremarkable antenatal course was noted to 
have poor weight gain during the early months of her life. At the age of 7 
months, her parents reported one episode of choking during a swimming 
outing in a chlorinated pool. There was no concern regarding near drowning 
or requirement for poolside resuscitation however the parents decided to take 
the  infant  to her local hospital for review. An admission chest radiograph was 
performed and demonstratedemphysematous changes within the right lung, 
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which would not have been consistent with the clinical history. A chest CT 
was performed during the same admission which confirmed the radiograph 
findings of hyperinflation of the right upper and middle lobes with areas of 
bronchial wall thickening and dilatation in the lower lobes (Figure 4). 
 
The patient continued to have multiple episodes of intercurrent pulmonary 
infections necessitating prolonged hospital admission and escalation in 
ventilatory support with 100% oxygen via high flow nasal cannulae with a 
maximal FiO2 of 45%.  
 
During her hospital admission, she was discovered to have a PDA which was 
ligated. Transpulmonary gradient pressures measured at this time were 
elevated and a course of sildenafil initiated. A transthoracic echocardiogram 
revealed a hypertrophied right ventricle with preserved function and no 
significant chamber dilatation.  
 
Given the destructive lung changes, genetic analysis was sought and a 
mutation of the FLNA gene was identified. Due to the known association 
between FLNA mutation and neurological abnormalities, an MRI of the brain 
was performed demonstrating periventricular nodular heterotopia (PVNH), 
although the patient was not suffering from any neurological symptoms at this 
stage. 
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During the course of the following months the chest radiograph changes were 
progressively deteriorating (Figure 5) with increasing right upper lobe 
hyperinflation, left sided mediastinal shift and reduced aeration within the left 
lung. After careful consideration and discussion at the respiratory multi-
disciplinary team (MDT) meeting, a right upper lobectomy was performed  at 
18 months of age. The histopathology results of the resected lobe 
demonstrated emphysematous changes but without significant inflammatory 
lung disease (Figure 6).   
 
The patient made a slow, but successful recovery post-lobectomy with 
improvements in chest symptoms, saturating up to 98% on room air. She has 
had minor viral illnesses requiring additional supplemental oxygen but no 
further respiratory support. She is currently 4 years old and progressing well 
clinically. Her pulmonary vasodilators are slowly being weaned and she no 
longer requires diuretic medications. The latest echocardiogram does 
continue to demonstrate some signs of elevated pulmonary arterial pressure 
and therefore she continues to be monitored in our institution’s outpatient 
clinic for signs of aortic root dilatation or valvulopathy.  
 
Case 3  
This female infant was born via vaginal delivery through meconium stained 
liquor at 40 +4 weeks gestation. At birth she was transferred and intubated on 
the neonatal intensive care unit (NICU) due to increased work of breathing 
and low oxygen saturations. The patient continued to have a difficult neonatal 
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course requiring high flow oxygen ventilation, nitric oxide and inotropic 
support.  
 
After multiple unsuccessful attempts at extubation, the patient was transferred 
to a tertiary specialist children’s hospital for further care. A chest CT at this 
stage, aged 2 months, revealed pan lobular emphysematous changes within 
both lungs with hyperinflation of the upper lobes and right middle lobe (Figure 
7).  At three months of age she was successfully extubated and placed on 
non-invasive mechanical ventilation (NIV) support. A bronchoscopy at this 
time demonstrated left lower lobe bronchomalacia and multiple bronchial 
stenoses. A transthoracic echocardiography revealed a structurally normal 
heart without any evidence of pulmonary hypertension. 
 
After a prolonged course of NIV support and difficulty weaning from CPAP, 
the decision was made to site a tracheostomy at 6 months of age. The patient 
was slowly established on a portable ventilator via the tracheostomy with 
improvement in her baseline respiratory rate and work of breathing. She was 
then transferred to our institution for long term ventilation management. The 
admission chest radiograph (Figure 8) shows bilateral bronchial wall 
thickening with persistent hyperlucency and inflation of the upper lobes. 
 
During her inpatient stay, she was difficult to wean from ventilation, 
developing recurrent episodes of wheezing and bronchoconstriction which 
were responsive to Ipratropium bromide and Salbutamol. Genetic testing was 
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sought based on re-review of the external CT imaging. This was negative for 
cystic fibrosis and myotonin-protein kinase expansion but , which confirmed a 
novel variant missense mutation within the filamin A gene. Given the 
uncertainty regarding pathogenicity, the patient’s immediate family members 
were all reviewed and tested for FLNA gene mutation. The patient’s mother 
and younger sister were asymptomatic but found to have the identical 
missense mutation, and the patient’s father did not. After prolonged 
discussion and genetic consultation, given the absence of other explainable 
lung disease, the consensus hypothesis was that the lung disease may have 
been manifested by an invoked unfavourable X inactivation in the patient.  
 
Over the next years, the patient slowly improved with bronchodilator 
nebulization and satisfactory gas exchange on lower CPAP, tolerating periods 
on the Swedish nose during the day. She is now 3 years old and has had her 
tracheostomy removed within the last 6 months. She is continuing to gain 
weight and only requires the usage of bronchodilator inhalers for a recurrent 
wheeze. 
 
Case 4  
This female infant was born at 38 weeks gestation with a normal antenatal 
and immediate neonatal course. She was admitted to her local hospital with 
suspected viral bronchiolitis at 3 months of age and required supplemental 
oxygen. An echocardiogram at this time revealed a secundum ASD with 
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bidirectional flow, mildly dilated and hypertrophied right ventricle and right 
atrium as well as pulmonary hypertension. 
 
The chest radiograph appearances at this stage included right upper lobe 
hyperinflation with right middle lobe and left lower lobe atelectasis (Figure 9). 
The subsequent chest CT demonstrated dilatation of the central pulmonary 
artery with bilateral extensive chronic lung disease with nodular change and 
bronchial wall thickening. In addition, hyperinflation of the upper lobes 
bilaterally were seen (Figure 10). 
 
The patient was admitted to our institution for a hybrid procedure involving 
both cardiac catheterisation and cardiac MRI. These studies revealed a PDA, 
confirmed bidirectional flow through the ASD and significant pulmonary 
arterial hypertension. The systemic and pulmonary venous connections were 
normal.  
 
A respiratory consultation was sought and the pulmonary hypertension was 
presumed to be secondary to the diffuse lung disease. The patient was 
started on Bosentan in addition to her regular dose of Sildenafil. Investigations 
for aspiration, gastro-oesophageal reflux, immunodeficiency and cystic 
fibrosis were all negative.  
 
In view of the severe early onset cystic lung disease, she was screened for a 
Filamin A gene mutation, which was confirmed. She is currently 6 years old, 
Page 44 of 75
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
FLNA mutation – a newcomer to the ChILD classification 
Page 16 
 
 
and continues on supplementary oxygen support of 1L at home and 
pulmonary vasodilators. 
 
Discussion: 
Our case series has demonstrated a variable outcome and management 
course for four patients seen with confirmed FLNA gene mutations occurring 
with interstitial lung disease. One patient required surgical intervention in the 
form of a right upper lobectomy after which a dramatic clinical improvement 
was observed, two patients were treated with supplementary oxygen and 
ventilatory support with pulmonary arterial vasodilators and have 
demonstrated a steady but slow improvement in respiratory symptoms and 
one patient died in infancy having been treated with maximal medical 
therapies and multiple episodes of mechanical ventilatory support.  
 
Compared to the limited number of previously published cases (summarised 
in Table 2), our case series show similar features with our patients having an 
early age of onset of respiratory symptoms, presence of cardiac co-
morbidities, pulmonary arterial hypertension (seen on echocardiography) and 
in one patient, the confirmatory diagnosis of periventricular nodular 
heterotopia on brain MRI. On chest imaging, all our patients demonstrated 
features both on radiography and CT of predominantly upper lobe 
hyperinflation and segmental basal atelectasis. This echoes previous cases 
where imaging appearances have been described as those featuring a 
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combination of  bronchopulmonary dysplasia, bronchomalacia and congenital 
lobar emphysema1211.  
 
With regards to the cardiac co-morbidities, two of our patients were found to 
have a patent ductus arteriosis, which was also seen in 5 previously reported 
FLNA associated lung disease cases
76,1110
 and was the second commonest 
associated cardiac abnormality within 17.6% (6 patients) of patients with 
FLNA associated PVNH (second only to aortic valvular insufficiency)Error! 
Bookmark not defined.13. This illustrates the importance of echocardiographic 
findings in this cohort of patients and the need for future extended medical 
surveillance from a cardiovascular standpoint. 
 
Although one of our four cases was found to have PVNH on brain imaging, 
none of our cases reported neurological symptoms. This may be explained by 
the young age group or case mix of our cohort. Lange et al14 report in their 
large case series, of 34 patient with detailed clinical history and FLNA 
associated PVNH, many patients (n=10) had either none or minor 
neurological symptoms (e.g. headaches) whilst the remainder had seizure 
onset during adolescence or adulthood (n = 20). Interestingly, only 2 patients 
in this cohort had any respiratory symptoms described (these are not detailed 
further, apart from being described as ‘obstructive lung disease’). Whilst we 
acknowledge a strong association between FLNA mutation and PVNH exists, 
given the young age of our patients, lack of neurological symptoms and 
increased risk from general anaesthesia in order to perform the MRI studies 
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(due to their lung disease), this was not felt to be clinically indicated at the 
present stage. The patient’s’ parents have all been extensively counseled on 
associated anomalies in FLNA mutations, and should neurological symptoms 
arise, further neurological examinations would be arranged. 
 
In terms of treatment, in contrast to 4 other prior cases in the literature1110, 
none of the patients in our series required lung transplantation. Whilst one of 
our patients died at an early age and may not have been a suitable surgical 
candidate, transplantation may be an alternative treatment in severe cases 
where supportive therapies do not appear to work. Additionally, the individual 
FLNA mutations identified within our subgroup are all novel and provide a 
record by which future cases with FLNA mutations can be compared to help 
guide management and provide information on potential patient prognosis. In 
one of our cases (case 3), the genetic mutation was a missense variant 
mutation, highlighting a clinical diagnostic dilemma and necessitating genetic 
testing of several family members. In the absence of other explainable causes 
for the patient’s lung disease, this was assumed to be contributory and has 
been included in this case series in the hope that our findings may aid in 
patient counseling and for comparison to future similar cases to emerge in the 
medical literature. 
 
Genetic analysis and counseling can also aid family members, particularly in 
the setting of family planning, to determine options for prenatal genetic testing 
or preimplantation genetic diagnosis for further pregnancies.. However there 
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are limitations to this, one being the discovery of missense variant mutations 
as highlighted and described in case 3 which may pose a diagnostic dilemma. 
In addition, although our case series highlights the clinical and radiological 
findings of lung disease in patients with confirmed FLNA mutations, the 
spectrum of such lung disease is still to be established and there may be 
‘missed cases’ of FLNA mutation in patients with potentially milder forms of 
the disease, being treated and labeled as having ‘abnormalities of lung 
growth’. This may be an interesting area for further research work. 
 
The pathogenesis of lung disease associated with FLNA mutations is unclear 
but a variety of hypotheses have been proposed. One explanation may be 
due to abnormal binding properties between Filamin A and beta integrin cell 
adhesion receptors, crucial in airway development15. The association between 
FLNA mutation with connective tissue disorders16 may also suggest interplay 
with other gene abnormalities within the same functional pathway. These 
explanations have also been proposed to account for the associated cardiac 
anomalies in many observed cases of FLNA associated lung disease.  
 
An alternative mechanism may be from atypical interactions of Filamin A with 
the cystic fibrosis transmembrane regulator (CFTR) thereby destabilizing 
chloride channel function in the airways17. This is however felt to be a less 
likely cause for the pulmonary features as florid bronchiectasis and impaired 
mucociliary fluid clearance has only been described in one patient so far with 
FLNA mutation1211. Furthermore poor immunological function with a super- Formatted: Endnote
(Default) +Body (Cambria)
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added infective aetiology has been suggested due to the role played by 
Filamin A in T cell activation and interleukin production18, however patients 
with the FLNA mutation have not shown susceptibility to any specific 
organisms despite many of the patients in our case series regularly presenting 
to hospital in childhood with recurrent pulmonary infections. 
 
Conclusion 
We present the clinical radiological, cardiac and histological features of FLNA 
gene mutation ChILild. This diagnosis should be considered for atypical 
diffuse lung disease with the hallmark feature of marked hyperinflation19, 
predominantly in the upper lobe distribution with accompanying pulmonary 
arterial hypertension in the majority of cases. There may be a potential 
association with periventricular nodular heterotopia (PNH)1613. Whilst the 
treatment options may be predominantly supportive, our case series has 
shown that some clinical improvements may be achieved and that the 
prognosis is variable.  
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Image Legends 
Figure 1   
Chest radiograph of case 1 at age 3 months demonstrating hyperinflation and 
lucency within the left lung with mediastinal shift to the right. Fine interstitial 
thickening and septations are noted in the left lower zone. There is right upper lobe 
consolidation.  
 
Figure 2 (a-f) 
Case 1: Serial axial chest CT images (with lung windows) are displayed 
demonstrating lung changes with age. The top row (a to c) highlights imaging 
appearances within the upper, middle and lower zones respectively at 3 months of 
age. There is a moderate sized right pneumothorax with underlying ground glass 
change in the lung parenchyma. The left lung is hyperinflated with interlobular septal 
thickening and areas of air trapping. The bottom row (d to f) demonstrates lung 
appearances at 5 months of age reflecting on-going left lung hyperinflation and 
septal thickening. The pneumothorax is no longer present. 
 
Figure 3 
Haematoxylin and eosin stained histopathology images of (a) the initial wedge 
biopsy of lung including the pleura and (b) a representative post-mortem section of 
the patient’s lung from case 1. The wedge biopsy reveals simplification of the 
alveolar architecture with dilatation of the distal airspaces. There is peribronchial 
fibrosis and focal haemorrhage. The post-mortem section demonstrates thickened 
alveolar septa and contain double capillary loops. This appearance was present 
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throughout the lung and is the diagnostic feature of atypical congenital alveolar 
dysplasia. There is marked intra-alveolar oedema. Elsewhere within the lung there 
was fibrosis and airspace dilatation.  
 
Figure 4 
Case 2: Axial chest computed tomography images of the upper (a), middle (b) and 
lower (c) zones at four months of age. Right upper and middle lobe hyperinflation 
with patchy ground glass opacification and atelectasis are present within the left lung 
and right lower lobe.  
 
Figure 5 
Serial chest radiographs from case 2 performed at (a) 8 months of age and (b) 15 
months of age reveal progressive right sided hyperinflation, mediastinal shift to the 
left and diffuse ground glass opacification within the left lung. 
 
Figure 6 
Histopathology lung biopsy image from case 2 with elastic van Gieson staining. 
There is marked dilatation of the distal air spaces without thickening of the walls. The 
included muscular pulmonary arteries are thick walled in keeping with pulmonary 
arterial hypertension. There is also some artefactual alveolar haemorrhage. 
 
Figure 7 
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Case 3: Axial chest CT images of the (a) upper and (b) lower lobes at 2 months of 
age demonstrate upper lobe hyperinflation with sparse pulmonary vascular markings 
and bibasal medial atelectatic changes.  
 
Figure 8 
A supine chest radiograph of case 3 performed at 10 months of age demonstrates 
persistent upper lobe hyperinflation, flattening of both hemidiaphragms and perihilar 
airspace changes. The patient has a tracheostomy in situ at this stage and is fed via 
a nasogastric tube. 
 
Figure 9 
Chest radiograph of patient in case 4 performed at 8 months of age demonstrates 
right upper lobe hyperinflation and atelectasis within the right midzone and left lower 
lobe. 
 
Figure 10 
Axial chest computed tomography images of case 4 of the (a) upper lobes and (b 
and c) lung bases reveal marked overinflation of both upper lobes and the right 
middle lobe with bilateral lower lobe atelectasis 
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Table 1.  
Summary of patient characteristics, clinical outcomes and investigations with FLNA related lung disease 
  Case 1 Case 2 Case 3 Case 4 
Genetic sequencing 
analysis of FLNA 
exons 2-48 
 Heterozygous for 
c.88delG, p.(Ala30fs) 
Heterozygous for 
c.6496dupA, 
p.(lle2166fs) 
Heterozygous for 
c.1528G>A, 
p.(Ala510Thr) 
Heterozygous for 
c.2190_2193delTTAC, 
p(tyr731fs) 
 
Clinical Presentation 
Sex 
 
Female Female Female Female 
 Gestational Age 
  
36 + 5 weeks Term Term 38 + 0 weeks 
 Delivery Elective Caesarean 
section 
Vaginal delivery Vaginal delivery Vaginal delivery 
 Presentation 
 
Sudden onset shortness 
of breath at 3 months 
 
Choking episode at 7 
months 
 
Meconium aspiration at 
birth 
 
Viral bronchiolitis at 3 
months 
 
 
 
Clinical  
Outcome 
 
Died at 9 months age 
from respiratory arrest. 
 
Now 4 years old. 
Weaning off pulmonary 
vasodilators.  
No longer requires 
regular diuretics or  
supplemental 02.  
Now 3 years old.  
Gaining weight, 
tracheostomy 
decannulated in the last 
year.  
Requires bronchodilator 
inhalers for a recurrent 
wheeze. 
 
Now 6 years old. 
Still requiring 
supplemental O2 at 
home, pulmonary 
vasodilators and 
bronchodilator 
nebulisers. 
 
 
Initial 
Echocardiography 
findings 
 Pulmonary hypertension, 
small PDA and PFO. 
Large PDA, left to right 
shunting, significant 
pulmonary hypertension. 
Structurally normal heart. 
Small interatrial 
communication with left 
to right flow.  
No evidence for 
pulmonary hypertension. 
Secundum ASD with 
bidirectional flow, mildly 
dilated and 
hypertrophied right 
ventricle, right atrium 
and pulmonary 
hypertension  
Brain imaging  None performed 
No neurological 
symptoms 
MRI Brain demonstrated 
periventricular nodular 
heterotopia.  
No neurological 
symptoms 
None performed 
No neurological 
symptoms 
None performed 
No neurological 
symptoms 
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Pattern of 
abnormalities on 
chest radiographs 
 Left lung hyperinflation. 
Interstitial thickening in 
left lower zone. 
Mediastinal shift to the 
right. 
Right lobe consolidation. 
Progressive right lung 
hyperinflation 
Mediastinal shift to the 
left. 
 
Bilateral upper lobe 
hyperinflation 
Basal atelectasis 
 
Right upper lobe 
hyperinflation 
Right middle lobe and 
left lower lobe atelectasis 
 
Predominant 
abnormalities seen on 
chest CTs 
 Left upper lobe and 
lower lobe over-inflation 
Coarse septal thickening 
Right pneumothorax 
initially, later resolved. 
Right upper and middle 
lobe over-inflation 
Coarse septal thickening 
Lower lobe atelectasis 
Patchy ground glass 
changes in lower lobes 
Right upper and left 
upper lobe over-inflation 
Coarse septal thickening 
Lower lobe atelectasis 
 
Right upper and middle, 
left upper lobe over-
inflation 
Coarse septal thickening 
Lower lobe atelectasis 
 
 
Lung Histopathology 
 
 
Right lung wedge biopsy: 
Poor alveolar 
development and 
immaturity with mild 
thickening of the small 
arteries 
 
Post-mortem 
examination:  
Congenital alveolar 
dysplasia. No pulmonary 
cysts or evidence for 
active infection  
Right upper lobar 
resection: 
 Emphysematous 
changes but without 
significant inflammatory 
lung disease 
None None 
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Table 2.  
Summary of previously published patient characteristics, clinical outcomes and investigations with FLNA related lung disease 
  De Wit et al
7
 
2011 
Masurel-Paulet 
et al
6
 
2011 
Singh et al
10
 
2013 
Lord et al
8
 
2014 
Bickel et al
11
 
2015 
Eltahir et al
9
 
2016 
City, Country  Rotterdam, 
Netherlands 
Adelaide,  
Australia 
Texas,  
USA 
Montreal,  
Canada 
Florida,  
USA 
Riyadh,  
Saudi Arabia 
Number of Cases  1 1 4 1 1 1 
FLNA mutation  Missense mutation 
(c.220G>P.G74R) 
Mosaic nonsense 
mutation 
(c.994delG.P.K33
1X) 
3 patients had 
frameshift 
mutations, one 
had missense 
mutation in FLNA. 
Mutation location 
not stated.  
Truncating mutation 
(c.5683G>T,p.G1895) 
Mutation 
seen at 
(c.988-1 
G>C). 
Pathogenic 
variant 
(c.3153dupC
) in exon 21 
 
Clinical 
Presentation 
Sex 
 
Female Male 4  Female Female Female Female 
 
 
Clinical  
Outcome 
 
Still alive at 3 years 
of age, with normal 
cognitive 
development and 
delayed motor 
development. No 
seizures.  
Followed up and 
still alive at 6 
years of age – 
requires 
supplementary 
oxygen whilst 
sleeping.  
 
Mildly 
developmentally 
delayed, 
gastrostomy fed, 
suffers from mild 
aortic valve 
regurgitation. 
All patients 
underwent 
bilateral lung 
transplantation at 
15, 15, 6 and 5 
months of age. 
 
One patient 
underwent a 
second lung 
transplantation 
but died of viral 
pneumonia aged 
3 years old. 
 
Remaining 3 
patients are 
thriving and 8 
Alive at 22 months of 
age, no longer 
requiring supplemental 
oxygen. 
Alive at 9 
years of age.  
 
Continues to 
be seen at 
routine 
outpatient 
pulmonology 
clinic. 
The patient 
required 
prolonged 
oxygen 
support and 
mechanical 
ventilation 
whilst on 
maximal 
medical 
therapy until 
her death at 
aged 15 
months. 
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years, 1.7 years 
and 5 months 
post transplant.  
Surgical 
Intervention 
 
 Right middle lobe 
lobectomy before the 
age of 1 years old. 
Subtotal left upper 
lobectomy at 8 
months of age 
All 4 patients 
underwent lung 
transplantation. 
None None None 
 
Pattern of 
abnormalities on 
chest radiographs 
 Not stated Bilateral 
subsegmental 
atelectasis with 
hyperlucent areas 
in midzones. 
Not stated Initial radiographs 
reveals bilateral 
perihilar pulmonary 
infiltrates.  
 
Over time until 22 
months of age, there is 
progressive right upper 
and middle lobe 
overinflation with right 
lower lobe atelectasis.  
Not stated Subsegment
al atelectasis 
within the 
lower lobes 
and upper 
lobe air 
trapping 
 
Predominant 
abnormalities seen 
on chest CTs 
 Lobar emphysema of 
right middle lobe with 
displacement of 
mediastinal 
structures to the left 
and compression of 
left upper lobe 
Widespread 
peribronchial 
thickening, 
subsegmental 
collapse, 
eventration of the 
left 
hemidiaphragm 
All studies 
demonstrated 
severe pulmonary 
hyperinflation and 
hyperlucency 
simulating 
emphysema 
Patchy ground glass 
appearances with right 
upper lobe 
hyperinflation.  
 
Heterogenous areas of 
atelectasis and 
interlobular septal 
thickening, 
predominantly in the 
lower lobes . 
Ground glass 
opacification 
with areas of 
atelectasis 
and 
hyperinflation 
on initial 
imaging as 
infant. 
 
Subsequent 
CT at age 8 
years old 
demonstrate
d additional 
broncheictasi
s 
Bibasal lung 
atelectasis, 
overinflation 
of the right 
middle lobe 
and left 
upper lobe 
with 
enlargement 
of the main 
and proximal 
branch 
pulmonary 
arteries. 
 
Lung 
Histopathology 
 
 
Lung emphysema 
without inflammatory 
changes 
Panpulmonary 
emphysema with 
absence of 
bronchial cartilage 
Explanted lung 
tissue showed 
severe alveolar 
simplification and 
Mild to moderate 
chronic lung disease 
with alveolar 
simplification and 
None Lung biopsy 
showed 
alveolar 
simplification. 
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and hypertensive 
pulmonary 
vascular disease. 
moderate 
pulmonary 
arteriopathy. 
pulmonary 
hypertension. 
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Table 1.  
Summary of patient characteristics, clinical outcomes and investigations with FLNA related lung disease 
  Case 1 Case 2 Case 3 Case 4 
Genetic sequencing 
analysis of FLNA 
exons 2-48 
 Heterozygous for 
c.88delG, p.(Ala30fs) 
Heterozygous for 
c.6496dupA, 
p.(lle2166fs) 
Heterozygous for 
c.1528G>A, 
p.(Ala510Thr) 
Heterozygous for 
c.2190_2193delTTAC, 
p(tyr731fs) 
 
Clinical Presentation 
Sex 
 
Female Female Female Female 
 Gestational Age 
  
36 + 5 weeks Term Term 38 + 0 weeks 
 Delivery Elective Caesarean 
section 
Vaginal delivery Vaginal delivery Vaginal delivery 
 Presentation 
 
Sudden onset shortness 
of breath at 3 months 
 
Chocking episode at 7 
months 
 
Meconium aspiration at 
birth 
 
Viral bronchiolitis at 3 
months 
 
 
 
Clinical  
Outcome 
 
Died at 9 months age 
from respiratory arrest. 
 
Now 4 years old. 
Weaning off pulmonary 
vasodilators.  
No longer requires 
regular diuretics or  
supplemental 02.  
Now 3 years old.  
Gaining weight, 
tracheostomy 
decannulated in the last 
year.  
Requires bronchodilator 
inhalers for a recurrent 
wheeze. 
 
Now 6 years old. 
Still requiring 
supplemental O2 at 
home, pulmonary 
vasodilators and 
bronchodilator 
nebulisers. 
 
 
Initial 
Echocardiography 
findings 
 Pulmonary hypertension, 
small PDA and PFO. 
Large PDA, left to right 
shunting, significant 
pulmonary hypertension. 
Structurally normal heart. 
Small interatrial 
communication with left 
to right flow.  
No evidence for 
pulmonary hypertension. 
Secundum ASD with 
bidirectional flow, mildly 
dilated and 
hypertrophied right 
ventricle, right atrium 
and pulmonary 
hypertension  
Brain imaging  None performed 
No neurological 
symptoms 
MRI Brain demonstrated 
periventricular nodular 
heterotopia.  
No neurological 
symptoms 
None performed 
No neurological 
symptoms 
None performed 
No neurological 
symptoms 
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Pattern of 
abnormalities on 
chest radiographs 
 Left lung hyperinflation. 
Interstitial thickening in 
left lower zone. 
Mediastinal shift to the 
right. 
Right lobe consolidation. 
Progressive right lung 
hyperinflation 
Mediastinal shift to the 
left. 
 
Bilateral upper lobe 
hyperinflation 
Basal atelectasis 
 
Right upper lobe 
hyperinflation 
Right middle lobe and 
left lower lobe atelectasis 
 
Predominant 
abnormalities seen on 
chest CTs 
 Left upper lobe and 
lower lobe over-inflation 
Coarse septal thickening 
Right pneumothorax 
initially, later resolved. 
Right upper and middle 
lobe over-inflation 
Coarse septal thickening 
Lower lobe atelectasis 
Patchy ground glass 
changes in lower lobes 
Right upper and left 
upper lobe over-inflation 
Coarse septal thickening 
Lower lobe atelectasis 
 
Right upper and middle, 
left upper lobe over-
inflation 
Coarse septal thickening 
Lower lobe atelectasis 
 
 
Lung Histopathology 
 
 
Right lung wedge biopsy: 
Poor alveolar 
development and 
immaturity with mild 
thickening of the small 
arteries 
 
Post-mortem 
examination:  
Congenital alveolar 
dysplasia. No pulmonary 
cysts or evidence for 
active infection  
Right upper lobar 
resection: 
 Emphysematous 
changes but without 
significant inflammatory 
lung disease 
None None 
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Table 2.  
Summary of previously published patient characteristics, clinical outcomes and investigations with FLNA related lung disease 
  De Wit et al
7
 
2011 
Masurel-Paulet 
et al
6
 
2011 
Singh et al
10
 
2013 
Lord et al
8
 
2014 
Bickel et al
11
 
2015 
Eltahir et al
9
 
2016 
City, Country  Rotterdam, 
Netherlands 
Adelaide,  
Australia 
Texas,  
USA 
Montreal,  
Canada 
Florida,  
USA 
Riyadh,  
Saudi Arabia 
Number of Cases  1 1 4 1 1 1 
FLNA mutation  Missense mutation 
(c.220G>P.G74R) 
Mosaic nonsense 
mutation 
(c.994delG.P.K33
1X) 
3 patients had 
frameshift 
mutations, one 
had missense 
mutation in FLNA. 
Mutation location 
not stated.  
Truncating mutation 
(c.5683G>T,p.G1895) 
Mutation 
seen at 
(c.988-1 
G>C). 
Pathogenic 
variant 
(c.3153dupC
) in exon 21 
 
Clinical 
Presentation 
Sex 
 
Female Male 4  Female Female Female Female 
 
 
Clinical  
Outcome 
 
Still alive at 3 years 
of age, with normal 
cognitive 
development and 
delayed motor 
development. No 
seizures.  
Followed up and 
still alive at 6 
years of age – 
requires 
supplementary 
oxygen whilst 
sleeping.  
 
Mildly 
developmentally 
delayed, 
gastrostomy fed, 
suffers from mild 
aortic valve 
regurgitation. 
All patients 
underwent 
bilateral lung 
transplantation at 
15, 15, 6 and 5 
months of age. 
 
One patient 
underwent a 
second lung 
transplantation 
but died of viral 
pneumonia aged 
3 years old. 
 
Remaining 3 
patients are 
thriving and 8 
Alive at 22 months of 
age, no longer 
requiring supplemental 
oxygen. 
Alive at 9 
years of age.  
 
Continues to 
be seen at 
routine 
outpatient 
pulmonology 
clinic. 
The patient 
required 
prolonged 
oxygen 
support and 
mechanical 
ventilation 
whilst on 
maximal 
medical 
therapy until 
her death at 
aged 15 
months. 
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years, 1.7 years 
and 5 months 
post transplant.  
Surgical 
Intervention 
 
 Right middle lobe 
lobectomy before the 
age of 1 years old. 
Subtotal left upper 
lobectomy at 8 
months of age 
All 4 patients 
underwent lung 
transplantation. 
None None None 
 
Pattern of 
abnormalities on 
chest radiographs 
 Not stated Bilateral 
subsegmental 
atelectasis with 
hyperlucent areas 
in midzones. 
Not stated Initial radiographs 
reveals bilateral 
perihilar pulmonary 
infiltrates.  
 
Over time until 22 
months of age, there is 
progressive right upper 
and middle lobe 
overinflation with right 
lower lobe atelectasis.  
Not stated Subsegment
al atelectasis 
within the 
lower lobes 
and upper 
lobe air 
trapping 
 
Predominant 
abnormalities seen 
on chest CTs 
 Lobar emphysema of 
right middle lobe with 
displacement of 
mediastinal 
structures to the left 
and compression of 
left upper lobe 
Widespread 
peribronchial 
thickening, 
subsegmental 
collapse, 
eventration of the 
left 
hemidiaphragm 
All studies 
demonstrated 
severe pulmonary 
hyperinflation and 
hyperlucency 
simulating 
emphysema 
Patchy ground glass 
appearances with right 
upper lobe 
hyperinflation.  
 
Heterogenous areas of 
atelectasis and 
interlobular septal 
thickening, 
predominantly in the 
lower lobes . 
Ground glass 
opacification 
with areas of 
atelectasis 
and 
hyperinflation 
on initial 
imaging as 
infant. 
 
Subsequent 
CT at age 8 
years old 
demonstrate
d additional 
broncheictasi
s 
Bibasal lung 
atelectasis, 
overinflation 
of the right 
middle lobe 
and left 
upper lobe 
with 
enlargement 
of the main 
and proximal 
branch 
pulmonary 
arteries. 
 
Lung 
Histopathology 
 
 
Lung emphysema 
without inflammatory 
changes 
Panpulmonary 
emphysema with 
absence of 
bronchial cartilage 
Explanted lung 
tissue showed 
severe alveolar 
simplification and 
Mild to moderate 
chronic lung disease 
with alveolar 
simplification and 
None Lung biopsy 
showed 
alveolar 
simplification. 
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and hypertensive 
pulmonary 
vascular disease. 
moderate 
pulmonary 
arteriopathy. 
pulmonary 
hypertension. 
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Figure 1. Chest radiograph of case 1 at age 3 months demonstrating hyperinflation and lucency within the 
left lung with mediastinal shift to the right. Fine interstitial thickening and septations are noted in the left 
lower zone. There is right upper lobe consolidation.  
Figure 1  
39x32mm (300 x 300 DPI)  
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Figure 2. Case 1: Serial axial chest CT images (with lung windows) are displayed demonstrating lung 
changes with age. The top row (a to c) highlights imaging appearances within the upper, middle and lower 
zones respectively at 3 months of age. There is a moderate sized right pneumothorax with underlying 
ground glass change in the lung parenchyma. The left lung is hyperinflated with interlobular septal 
thickening and areas of air trapping. The bottom row (d to f) demonstrates lung appearances at 5 months of 
age reflecting on-going left lung hyperinflation and septal thickening. The pneumothorax is no longer 
present.  
Figure 2  
250x127mm (300 x 300 DPI)  
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Figure 3. Haematoxylin and eosin stained histopathology images of (a) the initial wedge biopsy of lung 
including the pleura and (b) a representative post-mortem section of the patient’s lung from case 1. The 
wedge biopsy reveals simplification of the alveolar architecture with dilatation of the distal airspaces. There 
is peribronchial fibrosis and focal haemorrhage. The post-mortem section demonstrates thickened alveolar 
septa and contain double capillary loops. This appearance was present throughout the lung and is the 
diagnostic feature of atypical congenital alveolar dysplasia. There is marked intra-alveolar oedema. 
Elsewhere within the lung there was fibrosis and airspace dilatation.  
Figure 3  
241x91mm (300 x 300 DPI)  
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Figure 4. Case 2: Axial chest computed tomography images of the upper (a), middle (b) and lower (c) zones 
at four months of age. Right upper and middle lobe hyperinflation with patchy ground glass opacification and 
atelectasis are present within the left lung and right lower lobe.  
Figure 4  
248x77mm (300 x 300 DPI)  
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Figure 5. Serial chest radiographs from case 2 performed at (a) 8 months of age and (b) 15 months of age 
reveal progressive right sided hyperinflation, mediastinal shift to the left and diffuse ground glass 
opacification within the left lung.  
Figure 5  
58x27mm (300 x 300 DPI)  
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Figure 6. Histopathology lung biopsy image from case 2 with elastic van Gieson staining. There is marked 
dilatation of the distal air spaces without thickening of the walls. The included muscular pulmonary arteries 
are thick walled in keeping with pulmonary arterial hypertension. There is also some artefactual alveolar 
haemorrhage.  
Figure 6  
173x130mm (300 x 300 DPI)  
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Figure 7. Case 3: Axial chest CT images of the (a) upper and (b) lower lobes at 2 months of age 
demonstrate upper lobe hyperinflation with sparse pulmonary vascular markings and bibasal medial 
atelectatic changes.  
Figure 7  
246x91mm (300 x 300 DPI)  
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Figure 8. A supine chest radiograph of case 3 performed at 10 months of age demonstrates persistent upper 
lobe hyperinflation, flattening of both hemidiaphragms and perihilar airspace changes. The patient has a 
tracheostomy in situ at this stage and is fed via a nasogastric tube.  
Figure 8  
117x99mm (300 x 300 DPI)  
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Figure 9. Chest radiograph of patient in case 4 performed at 8 months of age demonstrates right upper lobe 
hyperinflation and atelectasis within the right midzone and left lower lobe.  
Figure 9  
135x101mm (300 x 300 DPI)  
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Figure 10. Axial chest computed tomography images of case 4 of the (a) upper lobes and (b and c) lung 
bases reveal marked overinflation of both upper lobes and the right middle lobe with bilateral lower lobe 
atelectasis  
Figure 10  
246x68mm (300 x 300 DPI)  
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